#508: ASCVD Risk & Lipids Update! PREVENT, ApoB, Lp(a) + Next-Gen Therapies
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Claim CME for this episode at curbsiders.vcuhealth.org!
Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME
Show Segments
- Intro
- Case 1 from Kashlak
- Risk assessment framework
- ApoB and Non-HDL cholesterol
- Lipoprotein(a) and its importance
- The PREVENT risk score and its implications
- Statins and other lipid lowering therapies
- The role of diet and lifestyle in lipid management
- Case 2 from Kashlak
- Familial Hypercholesterolemia diagnosis and management
- Key takeaways
- Outro
Credits
- Producer, Writer, Shownotes, Infographic, and Cover art: Ben Furman, MPH
- Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Reviewer: Leah Witt, MD
- Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Technical Production: PodPaste
- Guest: Laurence Sperling, MD
Disclosures
Dr. Sperling reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.
Sponsor: Bucksbaum-Siegler Institute
If you want to learn more about what the Bucksbaum-Siegler Institute is doing and to nominate someone for the Clinical Excellence Award—you can check them out today. Visit bucksbauminstitute.uchicago.edu.
Sponsor: Grammarly
Sign up for FREE and experience how Grammarly can elevate your professional writing from start to finish. Visit Grammarly.com/podcast.
Sponsor: Continuing Education Company
Use promo code Curb30 to get 30% off all online courses and webcast. Visit CMEmeeting.org/curbsiders to learn more.
Sponsor: Freed
Use code: CURB50 to get $50 off your first month when you subscribe!
Pas encore de commentaire